Lifitegrast not checked

Lunan Better Pharmaceutical Co., LTD.

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
None yet
 
Trials
1 active
1 in total
Targets
 

What this is

How it works
Lymphocyte Function-Associated Antigen-1 Antagonist FDA class
How it’s given
“Instill one drop of the eye solution in each eye, twice a day (morning and evening, approximately 12 hours apart), for a treatment period of 12 weeks.”In the company’s words, NCT06879782 on ClinicalTrials.gov
Tested for
Dry Eye Disease (DED)
Main trialPhase 3
“This study is a multicenter, randomized, double-blind, placebo-controlled Phase III clinical trial designed to evaluate the efficacy and safety of Lifitegrast Ophthalmic Solution.”In the company’s words, NCT06879782 on ClinicalTrials.gov

Other drugs for Dry Eye Disease (DED)

All 44 drugs for Dry Eye Disease (DED)

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials1

TrialPhaseCompletesWhat it tests
Phase 3Recruiting 28 Mar 2026 Phase III Clinical Study of Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Lifitegrast

Following is part of Solo: you see every change to Lifitegrast the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in